BioSpace News Archive

Press Releases

TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference

December 9, 2024
·
6 min read
Press Releases

Scryb Announces Sale of its Joint Venture Interest in Fionet Rapid Response Group for CAD$3.5 million plus a Royalty

December 9, 2024
·
4 min read
Press Releases

Taiho Oncology Data at ASH Annual Meeting Highlight Progress in Oral Therapies for Patients with Blood Cancers

December 9, 2024
·
9 min read
Press Releases

Medincell and AIC Unveil New Positive Phase 3 Results for mdc-CWM: Major Subgroup Analysis Shows Reduced Pain and Opioid Use, and Accelerated Rehabilitation following Total Knee Replacement

December 9, 2024
·
2 min read
Press Releases

ADC Therapeutics Announces The Lancet Haematology Publication of Data from Investigator-Initiated Trial Evaluating ZYNLONTA® in Combination with Rituximab to Treat Relapsed/Refractory Follicular Lymphoma

December 9, 2024
·
9 min read
Press Releases

aTyr Pharma to Present Preclinical Research Demonstrating Anti-Fibrotic Effects of ATYR0101 in Lung and Kidney Fibrosis at Keystone Symposia on Fibrosis

December 9, 2024
·
6 min read
Press Releases

Bionomics Publishes the Positive Results from the Phase 2 ATTUNE Study of BNC210 in Patients with Post-Traumatic Stress Disorder in NEJM Evidence

December 9, 2024
·
5 min read
Press Releases

Mestag Therapeutics Announces Licensing of a Novel Inflammatory Disease Target from its RAFT Platform

December 9, 2024
·
2 min read
Press Releases

Actinogen randomizes first US participant in XanaMIA phase 2b/3 Alzheimer’s disease trial

December 9, 2024
·
9 min read
Press Releases

GRIN Therapeutics Presents Data from Honeycomb Trial of Radiprodil at the American Epilepsy Society Annual Meeting

December 9, 2024
·
6 min read